Updated:
Ausangate Capital
Ausangate Capital is a hedge fund headquartered in Miami Beach, United States, operating as a long/short equity fund. The firm focuses its investment strategy...
Ausangate Capital
Ausangate Capital is a hedge fund headquartered in Miami Beach, United States, operating as a long/short equity fund. The firm focuses its investment strategy on the biopharma sector, specifically targeting companies involved in developing drug products and technologies. By employing a long/short equity approach, Ausangate Capital seeks to provide capital to these specialized healthcare and life sciences firms. Its investment mandate is centered on supporting innovation within the biopharmaceutical industry. The firm evaluates opportunities among companies creating new therapeutic products and related technological advancements. Ausangate Capital's strategy combines sector-specific expertise with equity market positioning. Additional information about the firm's operations is available on its website at ausangatecapital.com.
General information
Firm type
Hedge Fund
Location
Country
United States
City
Miami Beach
Corporate office
Miami Beach, United States
Sector focus
Frequently asked questions
What type of fund is Ausangate Capital?
Ausangate Capital is a long/short equity hedge fund.
What sector does Ausangate Capital focus its investments on?
The firm focuses on the biopharma sector, providing capital to companies developing drug products and technologies.
Where is Ausangate Capital headquartered?
Ausangate Capital is headquartered in Miami Beach, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on hedge funds?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: